A protective role of IL-17 signaling in the intestine could explain the discrepancy in conclusions regarding the role of IL-17 in atherosclerosis using global but not cell-type-specific genetic or pharmacological manipulations in mouse models, where both pathogenic and protective functions of this cytokine could be neutralized. Here, IL17A is linked to atherosclerosis.